Research shows Nanoform method speeds up absorption and improves drug delivery

These results pave the way for improving absorption and increasing drug load while enabling simpler formulations to maximise patient benefit

picture of

Breaking News

IQVIA discusses supply chain resilience for CPhI Discover

Informa’s CPhI Discover virtual event is taking place from 17-28th May, and the company recently spoke with Aurelio ...

Research shows Nanoform method speeds up absorption and improves drug delivery

These results pave the way for improving absorption and increasing drug load while enabling simpler formulations to ...

Fareva completes high potency drug investment

The program started in 2016 at the site of Fareva La Vallée

Accelerating excipient development for inhalable dosage forms with QbD

Whether they are simply giving an oral dose the bulk it needs to permit handling and swallowing or performing more ...

Cardinal Health and FourKites partner on cognitive supply chain

FourKites’ work with Cardinal Health began during the onset of the COVID-19 pandemic with a pilot programme

Thermo Fisher and Artificial work to enhance COVID-19 testing platform

As part of the partnership, Thermo Fisher will provide feedback on aLab Suite functionalities and capabilities to ...

Manufacturing Chemist Live: A hybrid event

Taking place on 14-15 September, the event will put delegates ahead of the curve in the global pharmaceutical supply ...

CureVac and Rentschler Biopharma ramp up vaccine manufacture

The companies aim to produce more than 100 million doses of the CureVac vaccine per year in Laupheim

Eleva secures up to $74m to advance drug candidate

The company also announced the addition of Dr Ralf Smit to its executive board

Dissolution development: fast-track methodology for your highly soluble, highly permeable drug

Regarded as a key quality standard, dissolution testing is a powerful tool that’s used to measure a product’s ...

Derisking topical formulation development with multifactorial disease models

Today’s market for topical pharmaceuticals is valued at around $95 billion, with development efforts focused on small ...

The business and patient case for drug delivery device innovation in biosimilar products

Biosimilar development in the United States is at an important juncture, reports Darren Mansell, Regulatory Affairs ...

Vectura earns $11m milestone with Hikma generic launch

The launch of the product follows approval by the US FDA

Orgenesis signs joint venture with Cure Therapeutics

The agreement aims to to advance point-of-care development and commercialisation of cell and gene therapies